Isoxazole-Derived Aroylhydrazones and Their Dinuclear Copper(II) Complexes Show Antiproliferative Activity on Breast Cancer Cells with a Potentially Alternative Mechanism Of Action.
Jesica Paola RadaJéremy FortéGeoffrey GontardVincent CorcéMichèle SalmainNicolás A ReyPublished in: Chembiochem : a European journal of chemical biology (2020)
This paper reports the design, synthesis and cytotoxicity studies of two new isoxazole-derived aroylhydrazone ligands and their dinuclear copper(II) complexes. Compounds were fully characterized by various spectroscopic and analytical techniques. The molecular structures of four derivatives were confirmed by X-ray crystallography. The stability of the ligands and the complexes in aqueous medium was monitored spectroscopically. Both the ligands and the complexes were shown to interact with calf thymus DNA (ct-DNA). Additionally, structures containing a phenol pendant arm were significantly more cytotoxic than those carrying a pendant pyridine substituent, reaching sub-micromolar IC50 values on the triple-negative human breast cancer cell line MDA-MB-231. The metal chelation and transchelation ability of the compounds towards FeII , FeIII and ZnII ions was explored as a possible mechanism of action of these compounds.
Keyphrases
- breast cancer cells
- high resolution
- single molecule
- circulating tumor
- endothelial cells
- cell free
- computed tomography
- dual energy
- magnetic resonance imaging
- molecular docking
- quantum dots
- signaling pathway
- magnetic resonance
- ionic liquid
- cell proliferation
- molecular dynamics simulations
- circulating tumor cells
- case control
- anti inflammatory